The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)

Biochemical Pharmacology
G T TuckerT Y Chu

Abstract

The metabolism of methylenedioxymethamphetamine (MDMA, "ecstasy") was examined in a microsomal preparation of the yeast Saccharomyces cerevisiae expressing human debrisoquine hydroxylase, CYP2D6. Only one product, dihydroxymethylamphetamine (DHMA), was detected in the incubation mixture, and this product accounted for all of the substrate consumption at low concentration (10 microM). Mean +/- SD values of apparent Km(microM) and Vmax (nmol/min per nmol P450) for the demethylenation of (+) and (-)-MDMA at low concentrations (1-100 microM) were 1.72, 0.12 and 6.45, 0.10 and 2.90, 0.10 and 7.61, 0.06, respectively. At high concentrations (> 1000 microM) substrate inhibition was noted, with Ki values of 14.2 and 28.2 mM, respectively, for the (+) and (-) enantiomers. Incubation of MDMA isomers with human liver microsomes indicated that their demethylenation is deficient in the poor metabolizer phenotype. Thus, MDMA is converted to the catecholamine DHMA by CYP2D6, and this may give rise to genetically-determined differences in toxicity.

References

Sep 1, 1975·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A K ChoJ Jonsson
Aug 1, 1979·Journal of Medicinal Chemistry·J G CannonR J Naylor
Mar 14, 1992·Lancet·G R ScreatonS L Cohen
Mar 1, 1992·Chemical Research in Toxicology·L KoymansG M Donné-Op den Kelder
Apr 1, 1992·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Y KumagaiA K Cho
May 11, 1991·BMJ : British Medical Journal·A R Winstock
Jul 25, 1991·Biochemical Pharmacology·M S ChingS L Kelly
Oct 26, 1988·European Journal of Pharmacology·C J Schmidt, V L Taylor
Mar 27, 1987·JAMA : the Journal of the American Medical Association·G P DowlingR O Bost
Feb 1, 1987·Pharmacology, Biochemistry, and Behavior·R A GlennonM Yousif

Citations

Oct 28, 2005·European Journal of Drug Metabolism and Pharmacokinetics·M DostalekI Linhart
Mar 7, 2012·Archives of Toxicology·Márcia CarvalhoMaria de Lourdes Bastos
Jan 22, 2004·Psychopharmacology·Elizabeth Anne JohnsonDiane B Miller
Apr 15, 2004·Psychopharmacology·M Isabel ColadoA R Green
Sep 16, 2005·Psychopharmacology·Robert R FreedmanManuel E Tancer
Jan 16, 2007·European Journal of Nuclear Medicine and Molecular Imaging·M L Soto-MontenegroM Desco
Apr 18, 2009·Molecular Neurobiology·João Paulo CapelaFélix Carvalho
Feb 24, 1995·Neuroscience Letters·C JolivaltG Siest
Mar 29, 1996·Journal of Chromatography. B, Biomedical Applications·G EngelH K Kroemer
Apr 1, 1995·Toxicology in Vitro : an International Journal Published in Association with BIBRA·I Walker, M D Coleman
Jun 1, 1997·Biochemical Pharmacology·D WuE M Sellers
Sep 24, 1999·Pharmacology, Biochemistry, and Behavior·A MalpassF Bochner
Feb 24, 1999·Lancet·Rafael de la TorreJ Segura
Jun 6, 2003·Neuroscience and Biobehavioral Reviews·J C Cole, H R Sumnall
Mar 12, 1999·Neuroscience and Biobehavioral Reviews·K M HegadorenM Bourin
Apr 2, 2003·Pharmacology & Therapeutics·J C Cole, H R Sumnall
Jun 8, 2002·Toxicology Letters·J ObrockiR Thomasius
Mar 18, 2000·Toxicology Letters·Hans H MaurerFrank T Peters
Mar 10, 2001·Journal of Chromatography. B, Biomedical Sciences and Applications·M Brunnenberg, K A Kovar
Mar 18, 1999·Journal of Chromatography. B, Biomedical Sciences and Applications·J OrtuñoRafael de la Torre
Oct 26, 1999·Forensic Science International : Synergy·V FineschiE Turillazzi
Jul 31, 1998·Journal of Pharmaceutical and Biomedical Analysis·F Sadeghipour, J L Veuthey
Aug 24, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·C BurgessM Gill
Dec 4, 2003·Bioorganic & Medicinal Chemistry·Shahriar Haji-MomenianMilton L Brown
May 9, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Mireia SeguraRafael de la Torre
Apr 2, 1999·Alimentary Pharmacology & Therapeutics·A L Jones, K J Simpson
Jul 9, 2002·British Journal of Clinical Pharmacology·T C Gilhooly, A K Daly
Apr 15, 2003·Journal of Psychoactive Drugs·Franz X. VollenweiderMark Geyer
Dec 17, 2009·Toxicological Sciences : an Official Journal of the Society of Toxicology·Déborah HirtJean-Michel Scherrmann
Oct 19, 2006·Pharmacogenetics and Genomics·Helena CarmoJan G Hengstler
Oct 1, 1994·British Journal of Haematology·J C MarshE C Gordon-Smith
Aug 15, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Michael H BaumannMarilyn A Huestis
Feb 1, 1996·Journal of Clinical Pathology·C M MilroyA R Forrest
Jan 8, 2004·Psychosomatics·Jessica R OesterheldKelly L Cozza
Jan 5, 2002·Pharmacotherapy·C J Teter, S K Guthrie
Apr 5, 2011·Clinical Pharmacokinetics·Samanta Yubero-LahozRafael de la Torre
Jul 29, 2005·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Zivorad MalicevićMarina Jovanović
Dec 14, 2011·The Veterinary Quarterly·Irene Antolino-LoboMajorie B M van Duursen
Apr 11, 2009·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Aree ChoodumNorman W Smith
Aug 24, 1999·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M V BachG B Baker
Nov 5, 2015·Drug and Alcohol Dependence·Johanna J Nugteren-van LonkhuyzenLaura Hondebrink
Mar 2, 2016·Forensic Science International : Synergy·Merete VevelstadMarianne Arnestad
Dec 2, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Thelma SchiltWim van den Brink
Dec 13, 2006·Toxicology·Helena CarmoJan G Hengstler
Nov 18, 2006·Neuroscience and Biobehavioral Reviews·Kelly Allott, Jennifer Redman
Jun 8, 2012·British Journal of Pharmacology·Zhong-Ze FangFrank J Gonzalez
Mar 25, 2014·British Journal of Pharmacology·A Richard GreenK C F Fone
May 8, 2002·Pediatric Clinics of North America·Stephen C KoestersChristiana R Rajasingham
May 8, 2003·Journal of Toxicology. Clinical Toxicology·David G E CaldicottRod J Irvine
May 6, 2006·Anaesthesia·M R Duffy, M Swart
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay
Jun 4, 2015·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Andrew StolbachPaul Pham
Nov 12, 2013·Toxicology in Vitro : an International Journal Published in Association with BIBRA·C DowneyK M O'Boyle
Jul 23, 2016·Proceedings of the National Academy of Sciences of the United States of America·Takuto KumanoMichihiko Kobayashi
Jun 15, 2007·The British Journal of Oral & Maxillofacial Surgery·M AhmedG R Hoffman
Aug 29, 2007·Journal of Pharmaceutical Sciences·Vijay V Upreti, Natalie D Eddington
Feb 16, 2006·Journal of Psychopharmacology·Linh M VanA Rostami-Hodjegan
Oct 26, 2005·The Journal of Emergency Medicine·Manish M PatelMichael A Miller
Feb 24, 1999·Lancet·M SchwabE U Griese
May 23, 2006·Journal of Psychopharmacology·Jiansong YangA Rostami-Hodjegan
Jul 2, 2004·Therapeutic Drug Monitoring·Rafael de la TorreJ Camí
Feb 4, 2012·Journal of Psychopharmacology·Katherine J AitchisonKim Wolff
Oct 5, 2011·Journal of Psychopharmacology·Kim WolffKatherine J Aitchison
Mar 3, 2006·Journal of Psychopharmacology·Neil Easton, Charles A Marsden
Oct 31, 2002·Human Psychopharmacology·Matthias E. Liechti, Franz X. Vollenweider
Jan 1, 1998·Addiction Biology·S M Riordan, R Williams
Jan 10, 2018·The Medico-legal Journal·Toby Boote
Jan 11, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Natalie E ZlebnikMarilyn E Carroll
Oct 6, 1998·The American Journal of Forensic Medicine and Pathology·R W ByardR J Lokan
Dec 20, 2018·Bioscience Reports·Iris Ucella de MedeirosAline Schwarz
Sep 17, 2008·Journal of Clinical Psychopharmacology·Brian O'MathúnaRafael de la Torre
Apr 4, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Winnie JengPeter G Wells
Oct 29, 2004·Drug Metabolism and Drug Interactions·David F V LewisMaurice Dickins
Apr 15, 2003·Journal of Psychoactive Drugs·Matthew J Baggott
Sep 21, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kaori YasudaToshiyuki Sakaki
Aug 12, 2015·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xu MaoJiang Zheng
Apr 15, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Irene Antolino-LoboMajorie B M van Duursen
Jul 19, 2003·Pharmacological Reviews·A Richard GreenM Isabel Colado
Sep 26, 2009·The Journal of Pharmacology and Experimental Therapeutics·J Gabrielsson, A R Green
Jan 9, 2018·Annual Review of Pharmacology and Toxicology·Arthur K Cho
Feb 6, 2003·Rapid Communications in Mass Spectrometry : RCM·Nieves PizarroRafael de la Torre
Aug 30, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Markus R MeyerHans H Maurer
Jul 10, 2002·Annals of the New York Academy of Sciences·J K FallonM Forsling
Sep 25, 2007·The Journal of Pharmacology and Experimental Therapeutics·M FarréRafael de la Torre
Apr 1, 1997·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M J de GrootN P Vermeulen
Jul 21, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Matthew L BanksMichael A Nader
Aug 26, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·A HeydariA Rostami-Hodjegan
Feb 15, 2000·British Journal of Clinical Pharmacology·Rafael de la TorreJ Camí
Jun 5, 2004·CNS Drug Reviews·Roland W Freudenmann, Manfred Spitzer
Aug 22, 2002·Drug and Alcohol Review·Linda R GowingRobert L Ali
Jul 1, 1997·Annals of Clinical Biochemistry·B V MurthyR G Wilkes
Feb 3, 1997·The Medical Journal of Australia·J M WhiteR J Irvine
Sep 24, 2002·The Annals of Pharmacotherapy·Tony Antoniou, Alice Lin-In Tseng

Related Concepts

alpha-methylepinine, (S)-isomer
Cytochrome P-450 Oxygenase
Epinine
Mixed Function Oxygenases
Microsomes, Liver
NADP
Saccharomyces cerevisiae
Transfection
3,4-Methylenedioxyamphetamine
N-Methyl-3,4-methylenedioxyamphetamine Hydrochloride

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.